Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EDETATE vs EFGARTIGIMOD ALFA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EDETATE vs EFGARTIGIMOD ALFA: Safety Overview

Metric EDETATE EFGARTIGIMOD ALFA
Total FAERS Reports 145 249
Deaths Reported 9 26
Death Rate 6.2% 10.4%
Hospitalizations 107 115
Average Patient Age 58.2 yrs 54.0 yrs
% Female Patients 51.1% 82.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Rising Pharma Holdings, Inc. argenx US
Route INTRAMUSCULAR INTRAVENOUS
Marketing Status Discontinued Prescription